Verizon's dividend yield and Merck’s growth lead the Dow Dogs. Read why they’re set for solid returns, with other top picks ...
Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
19h
Hosted on MSNWall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
We recently compiled a list of the 10 Best Dow Jones Dividend Stocks According to Wall Street Analysts. In this article, we ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
23hon MSN
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results